The Communiqué Amending the Communiqué on the Mergers and Acquisitions Subject to the Approval of the Turkish Competition Board No. 2022/2 (the “Amendment Communiqué”) has been published on the Official Gazette dated 4 March 2022 and numbered 31768. In brief, the Amendment Communiqué brings drastic changes for the notifiability analysis of the transactions, as it particularly (i) raises the turnover thresholds, (ii) introduces an exception for the technology undertakings subject to acquisitions and (iii) amends certain items for turnover calculation of the financial institutions. The guidelines on the implementation of the mergers and acquisitions have been also updated and published on the official website of the Turkish Competition Authority (“Authority”).
Relevant amendments are summarised on out notes. You can reach the full of briefing here.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
24 April 2026
Turkish competition board fines seventeen pharmaceutical companies for no-poach agreements and wage data exchange
On 8 April 2026, the Turkish Competition Board published its decision dated 11 September 2025 and numbered 25-34/810-474 concluding a broad…
22 April 2026
Fintech in Türkiye 2026 – law and practice
The fintech sector in Türkiye has been developing steadily over the past several years, with growth accelerating significantly in recent…
22 April 2026
Fintech in Türkiye 2026 – trends and developments
The fintech sector in Türkiye has been developing steadily over the past several years, with growth accelerating significantly in recent…
20 April 2026
Bill on digital copyright and online news content
Following the submission of the Digital Copyright Bill (“Digital Copyright Bill“) to the Presidency of the Grand National Assembly of…
15 April 2026
Just cause termination in disciplinary investigations under Turkish law
Heightened regulatory expectations and evolving corporate governance standards have placed internal investigations at the centre of…
13 April 2026
Recent developments in healthcare legislation – Issue 2026/1
The Guideline on Trust Practices in Clinical Trial Applications published by the Turkish Medicines and Medical Devices Agency was updated…